Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine for opioid demand in AIS after spinal fusion
NCT04950660Phase 4Completed
- Sponsor
- Children's Mercy Kansas City
- Start
- Dec 2019
- Primary completion
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postoperative pain comparing Caffeine arm with Placebo arm (2 arms). Primary endpoint: Total Post Operative Oral Morphine Milligram Equivalents per Kilogram at 7 days. Started Dec 2019; status: completed.
02
Drugs
caffeine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04950660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04950660.